Aaron M Gusdon1, Gino Gialdini1, Gbambele Kone1, Hediyeh Baradaran1, Alexander E Merkler1, Halinder S Mangat1, Babak B Navi1, Costantino Iadecola1, Ajay Gupta1, Hooman Kamel1, Santosh B Murthy2. 1. From the Department of Neurology, Weill Cornell Medicine, New York (A.M.G., A.E.M., H.S.M., B.B.N., C.I., H.K., S.B.M.); Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York (A.M.G., G.G., G.K., A.E.M., B.B.N., C.I., A.G., H.K., S.B.M.); and Department of Radiology, Weill Cornell Medicine, New York (H.B., A.G.). 2. From the Department of Neurology, Weill Cornell Medicine, New York (A.M.G., A.E.M., H.S.M., B.B.N., C.I., H.K., S.B.M.); Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York (A.M.G., G.G., G.K., A.E.M., B.B.N., C.I., A.G., H.K., S.B.M.); and Department of Radiology, Weill Cornell Medicine, New York (H.B., A.G.). sam9200@med.cornell.edu.
Abstract
BACKGROUND AND PURPOSE: Although preclinical studies have shown inflammation to mediate perihematomal edema (PHE) after intracerebral hemorrhage, clinical data are lacking. Leukocyte count, often used to gauge serum inflammation, has been correlated with poor outcome but its relationship with PHE remains unknown. Our aim was to test the hypothesis that leukocyte count is associated with PHE growth. METHODS: We included patients with intracerebral hemorrhage admitted to a tertiary-care stroke center between 2011 and 2015. The primary outcome was absolute PHE growth during 24 hours, calculated using semiautomated planimetry. Linear regression models were constructed to study the relationship between absolute and differential leukocyte counts (monocyte count and neutrophil-lymphocyte ratio) and 24-hour PHE growth. RESULTS: A total of 153 patients were included. Median hematoma and PHE volumes at baseline were 14.4 (interquartile range, 6.3-36.3) and 14.0 (interquartile range, 5.9-27.8), respectively. In linear regression analysis adjusted for demographics and intracerebral hemorrhage characteristics, absolute leukocyte count was not associated with PHE growth (β, 0.07; standard error, 0.15; P=0.09). In secondary analyses, neutrophil-lymphocyte ratio was correlated with PHE growth (β, 0.22; standard error, 0.08; P=0.005). CONCLUSIONS: Higher neutrophil-lymphocyte ratio is independently associated with PHE growth. This suggests that PHE growth can be predicted using differential leukocyte counts on admission.
BACKGROUND AND PURPOSE: Although preclinical studies have shown inflammation to mediate perihematomal edema (PHE) after intracerebral hemorrhage, clinical data are lacking. Leukocyte count, often used to gauge serum inflammation, has been correlated with poor outcome but its relationship with PHE remains unknown. Our aim was to test the hypothesis that leukocyte count is associated with PHE growth. METHODS: We included patients with intracerebral hemorrhage admitted to a tertiary-care stroke center between 2011 and 2015. The primary outcome was absolute PHE growth during 24 hours, calculated using semiautomated planimetry. Linear regression models were constructed to study the relationship between absolute and differential leukocyte counts (monocyte count and neutrophil-lymphocyte ratio) and 24-hour PHE growth. RESULTS: A total of 153 patients were included. Median hematoma and PHE volumes at baseline were 14.4 (interquartile range, 6.3-36.3) and 14.0 (interquartile range, 5.9-27.8), respectively. In linear regression analysis adjusted for demographics and intracerebral hemorrhage characteristics, absolute leukocyte count was not associated with PHE growth (β, 0.07; standard error, 0.15; P=0.09). In secondary analyses, neutrophil-lymphocyte ratio was correlated with PHE growth (β, 0.22; standard error, 0.08; P=0.005). CONCLUSIONS: Higher neutrophil-lymphocyte ratio is independently associated with PHE growth. This suggests that PHE growth can be predicted using differential leukocyte counts on admission.
Authors: Sebastian Urday; Lauren A Beslow; David W Goldstein; Anastasia Vashkevich; Alison M Ayres; Thomas W K Battey; Magdy H Selim; W Taylor Kimberly; Jonathan Rosand; Kevin N Sheth Journal: Stroke Date: 2015-02-26 Impact factor: 7.914
Authors: Miguel Gonzalo Domínguez; Cristina Hernández; Pablo Ruisoto; Juan A Juanes; Alberto Prats; Tomás Hernández Journal: J Med Syst Date: 2016-05-05 Impact factor: 4.460
Authors: Sebastian Urday; W Taylor Kimberly; Lauren A Beslow; Alexander O Vortmeyer; Magdy H Selim; Jonathan Rosand; J Marc Simard; Kevin N Sheth Journal: Nat Rev Neurol Date: 2015-01-27 Impact factor: 42.937
Authors: Santosh B Murthy; Yogesh Moradiya; Jesse Dawson; Kennedy R Lees; Daniel F Hanley; Wendy C Ziai Journal: Stroke Date: 2015-09-22 Impact factor: 7.914
Authors: Chitra Venkatasubramanian; Michael Mlynash; Anna Finley-Caulfield; Irina Eyngorn; Rajalakshmi Kalimuthu; R W Snider; Christine Anne Wijman Journal: Stroke Date: 2010-12-16 Impact factor: 7.914
Authors: Alex M Dickens; Luis B Tovar-Y-Romo; Seung-Wan Yoo; Amanda L Trout; Mihyun Bae; Marlene Kanmogne; Bezawit Megra; Dionna W Williams; Kennith W Witwer; Mar Gacias; Nino Tabatadze; Robert N Cole; Patrizia Casaccia; Joan W Berman; Daniel C Anthony; Norman J Haughey Journal: Sci Signal Date: 2017-04-04 Impact factor: 8.192
Authors: Stephan A Mayer; Nikolai C Brun; Joseph Broderick; Stephen Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: Aaron M Gusdon; Paul A Nyquist; Victor M Torres-Lopez; Audrey C Leasure; Guido J Falcone; Kevin N Sheth; Lauren H Sansing; Daniel F Hanley; Rachna Malani Journal: Stroke Date: 2019-11-20 Impact factor: 7.914
Authors: Pablo Hervella; Manuel Rodríguez-Yáñez; José Manuel Pumar; Paulo Ávila-Gómez; Andrés da Silva-Candal; Ignacio López-Loureiro; Elena Rodríguez-Maqueda; Clara Correa-Paz; José Castillo; Tomás Sobrino; Francisco Campos; Ramón Iglesias-Rey Journal: Neurology Date: 2020-03-27 Impact factor: 9.910